Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by High Absorption Coq10 Product

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07530250Not ApplicableCompletedPrimary

Assessing Two Coenzyme Q10 Products in Men and Women

NCT02415114Phase 1CompletedPrimary

An Open Label Study Evaluating the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10

Showing all 2 trials

Research Network

Common Treatments

  • High Absorption Coq10 Product1
  • Omega Q Plus Resveratrol With 50mg Coq101
  • Standard Coq10 Product1

Active Sponsors

  • KGK Science Inc.1
  • Pharmavite LLC1
  • Healthy Directions, LLC1
  • Midwest Center for Metabolic and Cardiovascular Research1

Top Investigators

Related Conditions

  • Coq10 Blood Levels With Statin Use1

Activity Timeline